Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website-Reference-Cited by-同舟云学术

Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website

Published:2013-04-21 Issue:1 Volume:13 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Everitt Hazel,Moss-Morris Rona,Sibelli Alice,Tapp Laura,Coleman Nicholas,Yardley Lucy,Smith Peter,Little Paul

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/1471-230X-13-68/fulltext.html

Reference30 articles.

1. British Society of Gastroenterology: Care of patients with gastrointestinal disorders in the United Kingdom: a strategy for the future. Gut. 2007, 56: 1-56.

2. Akehurst R, Kaltenthaler E: Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut. 2001, 48 (2): 272-282. 10.1136/gut.48.2.272.

3. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P: Guidelines for the management of Irritable Bowel Syndrome. Gut. 2007, 56 (12): 1770-1798. 10.1136/gut.2007.119446. 8-5-2007.

4. Prior A, Whorwell PJ: Double blind study of ispaghula in irritable bowel syndrome. Gut. 1987, 28 (11): 1510-1513. 10.1136/gut.28.11.1510.

5. NICE: Irritable bowel syndrome in adults. 2008, NICE, http://guidance.nice.org.uk/CG61 ,

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Current State of Digital Therapeutics for Irritable Bowel Syndrome;Clinical Gastroenterology and Hepatology;2024-02

2. Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial;Gut;2024-01-08

3. Shared decision-making improving efficacy in diarrhoea-dominant irritable bowel syndrome in Chinese outpatient setting: protocol of a prospective, randomised controlled trial;BMJ Open;2023-12

4. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet;2023-11

5. Experiences of Irritable Bowel Syndrome Patients in a Virtual Yoga Program: Qualitative Findings from a Clinical Trial;Digestive Diseases and Sciences;2023-11-01